Aardvark Therapeutics AARD
NASDAQ AARD
$4.41 +0.51 (+13.08%)
At close: Oct 21, 2026 · 4:00 PM EDT

Aardvark Therapeutics (AARD) Non-Current Assets (2024 - 2026)

Updated

Aardvark Therapeutics (AARD) recorded Non-Current Assets of $799,000 in Q2 2026, down 70.5% from $2.71 million a year earlier and down 84.1% from the prior quarter.

Analysis

Aardvark Therapeutics (AARD) Non-Current Assets (2024 - 2026) Analysis & Trends

At the end of FY2025, Aardvark Therapeutics reported Non-Current Assets of $5.3 million, up 57.1% from FY2024.

  • Across earlier years, Non-Current Assets came in at $3.37 million in FY2024.
  • Per Business Quant, the preceding three quarters came in at $5.01 million (Q1 2026), $5.3 million (Q4 2025) and $4.02 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 77.61 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 141.29 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 101.45 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 125.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 94.68 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 87.87 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 60.68 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 35.42 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 159.77 Bn
10 Aardvark Therapeutics 96.45 Mn 22.55 Mn - 799,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 799,000.00
Mar 31, 2026 5.01 Mn
Dec 31, 2025 5.30 Mn
Sep 30, 2025 4.02 Mn
Jun 30, 2025 2.71 Mn
Mar 31, 2025 2.47 Mn
Dec 31, 2024 3.37 Mn
API Access

Aardvark Therapeutics Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=AARD&period=max&api_key=YOUR_API_KEY